文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Mitophagy Induced by Metal Nanoparticles for Cancer Treatment.

作者信息

Mundekkad Deepa, Cho William C

机构信息

Centre for NanoBioTechnology (CNBT), Vellore Institute of Technology, Vellore 632014, India.

Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR, China.

出版信息

Pharmaceutics. 2022 Oct 24;14(11):2275. doi: 10.3390/pharmaceutics14112275.


DOI:10.3390/pharmaceutics14112275
PMID:36365094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9699542/
Abstract

Research on nanoparticles, especially metal nanoparticles, in cancer therapy is gaining momentum. The versatility and biocompatibility of metal nanoparticles make them ideal for various applications in cancer therapy. They can bring about apoptotic cell death in cancer cells. In addition to apoptosis, nanoparticles mediate a special type of autophagy facilitated through mitochondria called mitophagy. Interestingly, nanoparticles with antioxidant properties are capable of inducing mitophagy by altering the levels of reactive oxygen species and by influencing signaling pathways like PINK/Parkin pathway and P13K/Akt/mTOR pathway. The current review presents various roles of metal nanoparticles in inducing mitophagy in cancer cells. We envision this review sheds some light on the blind spots in the research related to mitophagy induced by nanoparticles for cancer treatment.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/9699542/1528796ef3fb/pharmaceutics-14-02275-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/9699542/065c032a99c2/pharmaceutics-14-02275-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/9699542/069447d75a8e/pharmaceutics-14-02275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/9699542/2505ff9e1372/pharmaceutics-14-02275-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/9699542/f062624a7c4f/pharmaceutics-14-02275-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/9699542/91a2568275b4/pharmaceutics-14-02275-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/9699542/1528796ef3fb/pharmaceutics-14-02275-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/9699542/065c032a99c2/pharmaceutics-14-02275-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/9699542/069447d75a8e/pharmaceutics-14-02275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/9699542/2505ff9e1372/pharmaceutics-14-02275-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/9699542/f062624a7c4f/pharmaceutics-14-02275-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/9699542/91a2568275b4/pharmaceutics-14-02275-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c421/9699542/1528796ef3fb/pharmaceutics-14-02275-g006.jpg

相似文献

[1]
Mitophagy Induced by Metal Nanoparticles for Cancer Treatment.

Pharmaceutics. 2022-10-24

[2]
The Mitochondrial Deubiquitinase USP30 Regulates AKT/mTOR Signaling.

Front Pharmacol. 2022-2-17

[3]
Zinc oxide nanoparticles induce toxicity in CAL 27 oral cancer cell lines by activating PINK1/Parkin-mediated mitophagy.

Int J Nanomedicine. 2018-6-20

[4]
Zinc oxide nanoparticles induce toxicity in diffuse large B-cell lymphoma cell line U2932 via activating PINK1/Parkin-mediated mitophagy.

Biomed Pharmacother. 2023-8

[5]
Involvement of PINK1/parkin-mediated mitophagy in ZnO nanoparticle-induced toxicity in BV-2 cells.

Int J Nanomedicine. 2017-3-8

[6]
UVB-induced inactivation of manganese-containing superoxide dismutase promotes mitophagy via ROS-mediated mTORC2 pathway activation.

J Biol Chem. 2019-3-11

[7]
Neuroprotection of Andrographolide against Neurotoxin MPP-Induced Apoptosis in SH-SY5Y Cells via Activating Mitophagy, Autophagy, and Antioxidant Activities.

Int J Mol Sci. 2023-5-10

[8]
Enhancing of Nanocatalyst-Driven Chemodynaminc Therapy for Endometrial Cancer Cells Through Inhibition of PINK1/Parkin-Mediated Mitophagy.

Int J Nanomedicine. 2021

[9]
Low abundance of mitophagy markers is associated with reactive oxygen species overproduction in cows with fatty liver and causes reactive oxygen species overproduction and lipid accumulation in calf hepatocytes.

J Dairy Sci. 2022-9

[10]
Parkin and Nrf2 prevent oxidative stress-induced apoptosis in intervertebral endplate chondrocytes via inducing mitophagy and anti-oxidant defenses.

Life Sci. 2019-12-28

引用本文的文献

[1]
Neurogrit Gold Attenuates 6-OHDA-Induced Dopaminergic Neurodegeneration in Parkinson's Model of Caenorhabditis elegans by Reducing α-Synuclein Accumulation and Pink/Pdr-1 Driven Mitochondrial Dysfunction.

CNS Neurosci Ther. 2025-5

[2]
Cynaropicrin Suppresses Cell Proliferation by Inducing Mitophagy through p38 MAPK-Mediated Mitochondrial ROS Generation in Human Hepatocellular Carcinoma Cells.

J Microbiol Biotechnol. 2025-4-24

[3]
PSMA2 promotes chemo- and radioresistance of oral squamous cell carcinoma by modulating mitophagy pathway.

Cell Death Discov. 2025-1-10

[4]
FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production.

Redox Biol. 2024-9

[5]
Astaxanthin Inhibits HO-Induced Excessive Mitophagy and Apoptosis in SH-SY5Y Cells by Regulation of Akt/mTOR Activation.

Mar Drugs. 2024-1-24

[6]
Current Overview of Metal Nanoparticles' Synthesis, Characterization, and Biomedical Applications, with a Focus on Silver and Gold Nanoparticles.

Pharmaceuticals (Basel). 2023-10-4

[7]
Editorial: Autophagy modulation in cancer treatment utilizing nanomaterials and nanocarriers.

Front Oncol. 2023-6-6

[8]
Mesoporous Silica-Based Nanoplatforms Are Theranostic Agents for the Treatment of Inflammatory Disorders.

Pharmaceutics. 2023-1-28

本文引用的文献

[1]
STOML2 restricts mitophagy and increases chemosensitivity in pancreatic cancer through stabilizing PARL-induced PINK1 degradation.

Cell Death Dis. 2023-3-11

[2]
Mitochondria-targeted nanoparticles (mitoNANO): An emerging therapeutic shortcut for cancer.

Biomater Biosyst. 2021-8-13

[3]
Antitumor Activity of Chitosan-Coated Iron Oxide Nanocomposite Against Hepatocellular Carcinoma in Animal Models.

Biol Trace Elem Res. 2023-3

[4]
Zinc oxide nanoparticles inhibit osteosarcoma metastasis by downregulating β-catenin via HIF-1α/BNIP3/LC3B-mediated mitophagy pathway.

Bioact Mater. 2022-5-13

[5]
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response.

J Exp Clin Cancer Res. 2022-3-22

[6]
Nanoparticles in Clinical Translation for Cancer Therapy.

Int J Mol Sci. 2022-2-1

[7]
Nanotherapeutics in autophagy: a paradigm shift in cancer treatment.

Drug Deliv Transl Res. 2022-11

[8]
Cancer Therapy by Silver Nanoparticles: Fiction or Reality?

Int J Mol Sci. 2022-1-13

[9]
The surface coating of iron oxide nanoparticles drives their intracellular trafficking and degradation in endolysosomes differently depending on the cell type.

Biomaterials. 2022-2

[10]
The role of FUNDC1 in mitophagy, mitochondrial dynamics and human diseases.

Biochem Pharmacol. 2022-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索